-
Via annual Bridge Summit to focus on AI licensing
Read more: Via annual Bridge Summit to focus on AI licensingVia Licensing Alliance’s fourth-ever annual Bridge Summit, due to take place next week, will feature AI infrastructure and data center licensing discussions throughout its conference, as well as licensor meetings dedicated to its newly launched DRAM pool.
-
Roborock turns the tables on Ecovacs: first UPC suit escalates patent war across U.S., Europe, China
Read more: Roborock turns the tables on Ecovacs: first UPC suit escalates patent war across U.S., Europe, ChinaRoborock has filed its first UPC infringement suit against Ecovacs, turning their UPC dispute into a two-way fight. Following two reported German injunction wins and the reversal of Ecovacs’ inspection order, the new Munich action escalates a patent battle between Chinese rivals spanning China, Europe and the U.S.
-
UPC Roundup (1 week): CoA addresses pre-grant non-infringement actions; Munich LD revokes third Maxell patent; and more
Read more: UPC Roundup (1 week): CoA addresses pre-grant non-infringement actions; Munich LD revokes third Maxell patent; and moreThis is a summary of developments in and around the UPC in the calendar week of September 21, 2026.
-
Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possible
Read more: Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possibleIt will not be easy to defend this record patent damages verdict, given not only its outsized amount but also the deficiencies of the record that Apple has already alleged.
-
French consumer rights group urges Disney+ to compensate customers for switching off 4K following InterDigital injunctionsÂ
Read more: French consumer rights group urges Disney+ to compensate customers for switching off 4K following InterDigital injunctionsÂWhile Disney+ switched 4K back on again using a workaround in Germany, the streaming giant has not done the same in its other markets, including France.
-
Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuit
Read more: Mylan seeks declaratory judgment against Novo Nordisk over newly issued Wegovy patent, aiming to preempt a new Delaware lawsuitMylan has asked a Delaware court to declare a newly issued Novo Nordisk Wegovy patent invalid and not infringed, opening a new front in their long-running Hatch-Waxman fight over generic semaglutide.
-
EPO board of appeal rejects claim-saving approach to ambiguous amendments
Read more: EPO board of appeal rejects claim-saving approach to ambiguous amendmentsThe EPO Board of Appeal has rejected a claim-saving approach to ambiguous amendments in a Philip Morris e-cigarette patent dispute, holding that unresolved ambiguity can broaden a claim and create added-matter problems.Â
Follow Us
Latest Articles
- Via annual Bridge Summit to focus on AI licensing
- Roborock turns the tables on Ecovacs: first UPC suit escalates patent war across U.S., Europe, China
- UPC Roundup (1 week): CoA addresses pre-grant non-infringement actions; Munich LD revokes third Maxell patent; and more
- BREAKING: Corteva and Inari settle big-ticket seed patent dispute that attracted DOJ statement of interest
- Jury awards Burford-funded Taction $5.7B against Apple, but verdict appears not too likely to be affirmed; even JMOL appears possible